Safety and Efficacy Study of Ex Vivo Immunotherapy for Treatment of Aplastic Anemia
Clinical trial NCT00399971 · UNKNOWN
Trial details
- NCT number
- NCT00399971
- Sponsor
- Shenzhen Zhongxing Yangfan Biotech Co. Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-11-01
- Primary completion
- 2009-06-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.